Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil and Stroke Recovery
NCT02628847Phase 1Terminated
- Sponsor
- University of Utah
- Start
- Mar 2012
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sildenafil in ischemic stroke (2 arms), sponsored by University of Utah. Primary endpoint: Fugl-Meyer Motor Assessment at 3 months. Started Mar 2012; status: terminated.
02
Drugs
sildenafil
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02628847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02628847.